Trade Mark Journal No.2026/034 21 August 2026

WO0000001930991 (1,5,42,44)

Office of origin: Switzerland

Date of International Registration:9 April 2026

Date of designation in the UK: 9 April 2026

International priority date claimed: 20 October 2025 (Switzerland) (840245)

Class 1: Active chemical ingredients used in the manufacture of cancer medicines and vaccines, medicines for treatment and prevention of dermatological or neurodegenerative diseases or disorders, as well as vaccines.
Class 5: Pharmaceutical products, substances and preparations, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medicinal preparations.
Class 42: Scientific services; scientific advice and information services; preparation of scientific reports; medical research; scientific research, in particular for prevention and treatment of cancer, dermatological or neurodegenerative diseases or disorders.
Class 44: Medical services, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical advice and information services; medical analysis services, in particular for diagnosis, treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; RNA or DNA analysis for prognosis and diagnosis of cancer, dermatological or neurodegenerative diseases or disorders; provision of information in the field of prevention, screening, diagnosis and treatment of cancers, dermatological or neurodegenerative diseases or disorders.

Torqur AG c/o Swiss Rockets AG

Representative: FMP Fuhrer Marbach & Partner, Konsumstrasse 16A,, Postfach, CH-3000 Bern 14, SWITZERLAND